Inside Business Covers ivWatch $14.8 million Funding Round

Sandra J. Pennecke covers ivWatch's $14.8 million round of funding to support operations, research and development of continuous IV monitoring technology.

By Sandra J. Pennecke
Jun 9, 2017

Gary Warren would like to type IV infiltration into a search engine in 10 years and find that the horrible images are all gone.

Warren, president and CEO of ivWatch LLC, a medical device firm based in Hampton, is working hard to solve the problems that occur when an IV infiltrates.

Infiltration occurs when fluid or medication leaks into the surrounding tissue and can be caused by improper placement or dislodgment of the IV. Read the full article.

Original article published in Inside Business on June 9, 2017.

Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**
Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**